🇺🇸 FDA

Company profile · Sponsor

Werewolf

Werewolf Therapeutics

HOWL · NYSE pharma WATERTOWN, MA, USA
Pipeline
2
Drugs
0
Patents
8

Quick answer

Werewolf (HOWL) is a pharma company. headquartered in WATERTOWN, MA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker HOWL
Exchange NYSE
Company type pharma
Headquarters WATERTOWN, MA, USA
SEC CIK 0001785530

Pipeline (2)

Search pipeline →

  1. WTX-330

    Werewolf

    Advanced or Metastatic Solid Tumors

    phase 2 small molecule active

    2 trials

  2. WTX-124

    Werewolf

    Metastatic Solid Tumor

    phase 1 small molecule active

    1 trial

Patents (8)

Search patents →

  1. US 12275769

    Activatable interleukin 12 polypeptides and methods of use thereof

    Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12076371

    Activatable cytokine polypeptides and methods of use thereof

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12036266

    Activatable cytokine polypeptides and methods of use thereof

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11981716

    Activatable interleukin-2 polypeptides and methods of use thereof

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11739132

    Separation moieties and methods of use thereof

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11535658

    Activatable interleukin-2 polypeptides and methods of use thereof

    Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11453710

    Activatable interleukin 12 polypeptides and methods of use thereof

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11352403

    Activatable interleukin-2 polypeptides and methods of use thereof

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Werewolf?

Werewolf (HOWL) is a pharma company. headquartered in WATERTOWN, MA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Werewolf sponsor?

We track 2 ClinicalTrials.gov-linked programs for Werewolf, including WTX-330 and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Werewolf company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.